Compare CTKB & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | ECX |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.1M | 612.1M |
| IPO Year | 2021 | N/A |
| Metric | CTKB | ECX |
|---|---|---|
| Price | $5.37 | $2.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.70 | $3.20 |
| AVG Volume (30 Days) | 785.4K | ★ 4.4M |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $196,828,000.00 | ★ $822,663,229.00 |
| Revenue This Year | $0.08 | $782.65 |
| Revenue Next Year | $5.45 | $32.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.99 |
| 52 Week Low | $2.37 | $0.76 |
| 52 Week High | $6.18 | $3.25 |
| Indicator | CTKB | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 65.05 |
| Support Level | $5.21 | $1.74 |
| Resistance Level | $5.70 | $2.20 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 38.64 | 83.93 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.